Journal: Nat Struct Mol Biol / Year: 2026 Title: Distinct amyloid-β filament fold in individuals with APP Flemish mutation. Authors: Peerzada Shariq Shaheen Khaki / Pablo Adrian Guillen-Poza / Carlton Wong / Chloe Kan / Rakesh Sharma / Rio Sugimura / Andrew C Robinson / Alejandro Valbuena / Roy Chun-Laam Ng / Yang Yang / Ruben Hervas / Abstract: The dominantly inherited Flemish mutation-an A692G substitution in the amyloid precursor protein, corresponding to an A21G change in amyloid-β (Aβ)-causes a rare, early-onset form of Alzheimer ...The dominantly inherited Flemish mutation-an A692G substitution in the amyloid precursor protein, corresponding to an A21G change in amyloid-β (Aβ)-causes a rare, early-onset form of Alzheimer disease characterized by pronounced cerebral amyloid angiopathy and unusually large senile plaque cores. Here, we report cryo-electron microscopy structures of amyloid filaments extracted from the postmortem parietal lobes of two individuals representing the only two known Flemish pedigrees worldwide. Although tau paired helical filaments were present, the predominant filaments comprise Aβ40-A21G, assembled as two identical protofilaments (D1-V40) packed with two-start helical symmetry. Aβ40-A21G and wild-type Aβ42 filaments share a substructure preceding the substitution site (Y10-F19); however, loss of the methyl group at residue 21 gives rise to a distinct arrangement, termed the 'Flemish fold', which differs from all previously characterized Aβ folds and is defined by a unique hydrophobic interface. Using a cell-based assay, we find that this distinctive fold is associated with the vascular tropism characteristic of the Flemish variant. Together, our structural and cellular data define a familial Alzheimer-disease-associated amyloid fold and provide insight into the molecular basis of Flemish-type dementia and cerebral hemorrhage.
History
Deposition
Sep 17, 2025
Deposition site: PDBJ / Processing site: PDBJ
Revision 1.0
Aug 5, 2026
Provider: repository / Type: Initial release
Revision 1.0
Aug 5, 2026
Data content type: EM metadata / Data content type: EM metadata / Provider: repository / Type: Initial release
Revision 1.0
Aug 5, 2026
Data content type: FSC / Data content type: FSC / Provider: repository / Type: Initial release
Revision 1.0
Aug 5, 2026
Data content type: Half map / Part number: 1 / Data content type: Half map / Provider: repository / Type: Initial release
Revision 1.0
Aug 5, 2026
Data content type: Half map / Part number: 2 / Data content type: Half map / Provider: repository / Type: Initial release
Revision 1.0
Aug 5, 2026
Data content type: Image / Data content type: Image / Provider: repository / Type: Initial release
Revision 1.0
Aug 5, 2026
Data content type: Primary map / Data content type: Primary map / Provider: repository / Type: Initial release
Data content type: EM metadata / Data content type: EM metadata / EM metadata / Group: Database references / Experimental summary / Data content type: EM metadata / EM metadata / EM metadata / Category: citation / citation_author / em_admin / Data content type: EM metadata / EM metadata / EM metadata Item: _citation.pdbx_database_id_PubMed / _citation.title / _em_admin.last_update
Data content type: EM metadata / Data content type: EM metadata / EM metadata / Group: Database references / Experimental summary / Data content type: EM metadata / EM metadata / Category: citation / em_admin Data content type: EM metadata / EM metadata ...EM metadata / EM metadata / EM metadata / EM metadata Item: _citation.journal_volume / _citation.page_first ..._citation.journal_volume / _citation.page_first / _citation.page_last / _em_admin.last_update
B: Amyloid-beta protein 40 J: Amyloid-beta protein 40 I: Amyloid-beta protein 40 H: Amyloid-beta protein 40 G: Amyloid-beta protein 40 A: Amyloid-beta protein 40 D: Amyloid-beta protein 40 C: Amyloid-beta protein 40 F: Amyloid-beta protein 40 E: Amyloid-beta protein 40
Resolution: 1.98 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 38206 / Symmetry type: HELICAL
Refinement
Resolution: 1.98→1.98 Å / Cor.coef. Fo:Fc: 0.821 / SU B: 4.481 / SU ML: 0.104 / ESU R: 0.066 Stereochemistry target values: MAXIMUM LIKELIHOOD WITH PHASES Details: HYDROGENS HAVE BEEN USED IF PRESENT IN THE INPUT